CLDN4 and urinary bladder cancer: In bladder cancer, CLDN4 promoter DNA hypomethylation was shown to correlate with CLDN4 overexpression, high-grade tumors, and invasion, and the increase in CLDN4 promoted anti-apoptosis, stemness, and epithelial-mesenchymal transition (EMT) [21].